bevantolol has been researched along with hydrochlorothiazide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Bolli, P; Fernandez, PG; Snedden, W; Vasdev, S | 1 |
| Lucas, CP; Morledge, JH; Tessman, DK | 1 |
2 trial(s) available for bevantolol and hydrochlorothiazide
| Article | Year |
|---|---|
Bevantolol attenuates thiazide stimulated renin secretion and catecholamine release in diuretic resistant hypertensives.
Topics: Adrenal Glands; Adrenergic beta-Antagonists; Adult; Catecholamines; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Middle Aged; Propanolamines; Renin; Vascular Resistance | 1989 |
Comparison of hydrochlorothiazide and hydrochlorothiazide plus bevantolol in hypertension.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Placebos; Propanolamines | 1985 |
1 other study(ies) available for bevantolol and hydrochlorothiazide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |